Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.200
-0.020 (-0.90%)
At close: Mar 6, 2026
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 416.48 million as of March 6, 2026. Its market cap has decreased by -43.47% in one year.
Market Cap
416.48M
Enterprise Value
708.93M
Revenue
737.49M
Ranking
n/a
PE Ratio
15.61
Stock Price
2.20
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 416.48M, a decrease of -39.66%. That is a compound annual growth rate of -9.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 416.48M | -20.66% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healius | 461.09M |
| Monash IVF Group | 259.11M |
| Integral Diagnostics | 886.19M |
| Cryosite | 60.77M |
| Rhythm Biosciences | 59.02M |
| Microba Life Sciences | 49.93M |
| INOVIQ | 46.46M |
| BCAL Diagnostics | 42.33M |